Dataset opportunity
Sfm Medical — Regulatory Records Dataset Opportunity
Moderate regulatory records dataset held by Sfm Medical, usable for Regulatory RAG and Compliance Copilots.
Score
73.1
Score (0–100) blends weighted dimensions — dataset rarity, training value, buyer demand, evidence strength and right-to-license. 70+ is deal-ready. See the scored dimensions below for the breakdown.Confidence
56%
Action
License
The recommended deal structure for this dataset: Acquire (full buyout), License (paid usage rights), Data Sharing Agreement (controlled access, no transfer of ownership), Partnership (co-development) or Annotation Program (labeling). Chosen from data ownership, licensing complexity and accessibility.Market size (indicative estimate)
Global RegTech market = $24.3B in 2025, CAGR 21.1%.
Lineage
How this lead was derived
The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.
Profile
Dataset profile
Type
Regulatory Records Dataset
Modality
Text
Sector
healthcare
Volume
Moderate
Freshness
Real-time
Rarity
Medium
Accessibility
Partial
Legal
Mixed ownership — licensing rights to clarify
Buyer persona
RegTech & compliance-AI vendors
Sfm Medical holds a comprehensive Regulatory Records Dataset in Text modality, containing crucial evidence from its manufacturing operations such as quality inspection logs, process parameters, and other regulatory filings. This structured and unstructured data is exceptionally well-suited for developing a Regulatory RAG system, enabling an AI to accurately retrieve and generate answers for complex compliance, quality assurance, and audit-related queries.
The business value of this data is highlighted by the rapidly expanding Global RegTech Market, which was valued at USD 24.3 billion in 2025 and is projected to grow at a 21.1% CAGR. [1] While the contract manufacturing model and highly regulated environment introduce access complexities, the rarity and depth of this industrial_data provide a distinct competitive advantage for AI buyers aiming to build robust, compliant solutions in this high-growth sector. ⚠ Diligence (valuable data, access to negotiate): Contract manufacturing model implies some data ownership may be shared with medtech clients.; Highly regulated medical environment requires strict compliance for data transfer.; Data includes sensitive manufacturing process parameters and quality inspection logs. · corporate: independent.
Scoring
Scored dimensions
Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.
This evidence collectively proves Sfm Medical owns a deep, proprietary repository of regulatory documentation from its medical device manufacturing operations. This dataset is a prime acquisition for RegTech vendors building AI tools for the healthcare sector, as it directly supports the development of sophisticated Regulatory RAG systems. In a global RegTech market projected to reach $24.3B by 2025, this unique collection of real-world EU MDR compliance and quality management files offers a distinct competitive advantage for training and validating next-generation compliance models.
See dimension details ↓- Legal Accessibility56
open/API access
How legally easy the data is to obtain and use — open/API access scores high; PII or regulated data scores low. - Acquisition Feasibility66
medium difficulty, independent
How realistic it is to actually obtain the data, given access difficulty and the holder's corporate structure. - Evidence Strength74
4 evidence types, 4 hits
How solid the proof is that the company holds this data — diversity of evidence types and number of hits. - Right to License36
ownership=mixed, licensing=rights_unclear
Whether the company can legally license the data out — based on ownership and licensing complexity. - Dataset Specificity90
dominant 'regulatory', sector healthcare, 3 specific types
How sharply the data targets a specific, hard-to-substitute domain or task. Niche, well-defined data scores higher than generic. - Dataset Rarity58
proprietary domain data (open lowers rarity)
How scarce and proprietary the data is. Unique domain data scores high; openly available data lowers it. - Dataset Volume58
4 evidence hits
Apparent scale of the data, inferred from the number of evidence hits and any explicit volume mentions. - Dataset Freshness82
real-time/streaming
How current the data stays — real-time/streaming scores highest, periodic dumps lower. - Training Value84
fit for Regulatory RAG
How useful the data is for the target AI use-case — its fit for model training or fine-tuning. - Buyer Demand95
AI buyer demand is extremely high, driven by the rapid 21.1% CAGR of the RegTech market which requires high-quality, domain-specific regulatory data for developing advanced compliance and risk management solutions. [1]
How strongly AI builders and companies are likely to want this data, based on market signals. - Corporate Independence90
independent
Whether the holder can decide alone — an independent company scores higher than a subsidiary of a large group. - Data Orientation22
0 data-appetite signals (0 types)
How actively the company invests in data, measured by its data-appetite signals (hires, products, APIs…). - Dormant Data Surplus92
surplus=high — proprietary data beyond what's already monetised
Volume and value of proprietary data this company holds BEYOND what it already monetises — the dormant surplus we can unlock. A company can sell some insights AND still sit on a far larger dormant asset. - ICP Audit75
✓ good target — Good target: sfm is an independent OEM/contract manufacturer of single-use medical devices, and the regulatory data generated as a by-product of its core business is a perfect fit, although its size is on the larger end for an SME. Issues: The company has around 380 employees across Germany and the Czech Republic, which places it at the upper limit or just beyond the typical SME definition. [18]; There are multiple similarly named but distinct legal entities (e.g., SFM Hospital Products GmbH, SF Medical Products GmbH), requiring precise targeting. [4, 20
- Deep Qualification70
⚠ needs review — Sfm Medical is a contract manufacturer for medtech clients, making the generated regulatory and quality data a by-product of services rendered. This strongly implies the data is owned by its clients, creating a significant obstacle to acquisition, despite the data's high relevance to the niche. [data is owned by the company's customers]
Evidence
Dataset evidence & lineage
What the typed evidence proves the company holds — reframed for clarity and set against the market.
Downloads / exports
This evidence demonstrates the holder possesses a library of downloadable regulatory certificates and authorizations, valuable for training models to recognize and classify official compliance documents.
Industrial data
This points to data from quality control systems within the manufacturing line, providing a direct link between production events and process reliability documentation.
Regulatory records
This is direct proof of owning high-value documentation covering the implementation of regulatory requirements, including an EU Quality Management System certificate under the Medical Device Regulation (MDR).
IoT / sensor data
This evidence outlines the scope of their industrial processes, including highly regulated activities like sterilization, indicating a broad base of associated operational and compliance data.
Marketplace
Dataset details
Detailed schema & sample available on access request.
Want this data?
Request access — we broker a secure deal room. Operator-reviewed, no automatic sharing.
This listing was generated automatically from public signals. It is not verified, and we are not affiliated with this company.
Coverage
Scanned sources
Deliverable
Premium dataset report
Sfm Medical Regulatory Records — a Moderate regulatory records dataset (Text modality) in the healthcare domain. Primary AI use-case: Regulatory RAG. Market signal: Global RegTech market = $24.3B in 2025, CAGR 21.1% (source: Grand View Research). Investment score 73.1/100 (confidence 0.56). Recommended action: License.
From the marketplace
Explore live data opportunities
Transcausse — فرصة مجموعة بيانات السجلات التنظيمية
View opportunity →الرعاية الصحيةPixee Medical — فرصة مجموعة بيانات التصوير الطبي
View opportunity →التمويلGefip — فرصة مجموعة بيانات السجلات التنظيمية
View opportunity →